| Application no. and date | 13158781.8 (espacenet) (Federated) (European Patent Register), 20080807 | | Patent/reg. no. and date | DK/EP 2604257, 20170628 | | Publication date | 20130619 | | Priority no. and date | US 954501 P, 20070807 | | EP pub. no. and date |
EP 2604257 20130619 | | Effective date | | | Applicant/owner | Acelrx Pharmaceuticals, Inc., 575 Chesapeake Drive
Redwood City, CA 94063, US | | Applicant ref. no. | V1707-034-DK | | Inventor | Palmer, Pamela, 140 Vasquez Avenue
San Francisco, CA California 94127, US,
Tzannis, Stelios, 35241 Wycombe Place
Newark, CA California 94560, US,
Schreck, Thomas, 140 Willowbrook Drive
Portola Valley, CA California 94028, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/4535 (2006.01) , A61K 31/5517 (2006.01) , A61K 9/00 (2006.01) , A61K 9/70 (2006.01) , A61P 25/20 (2006.01) | | Title | ORALE TRANSMUCOSALE DOSERINGSFORMER OMFATTENDE SUFENTANIL OG TRIAZOLAM | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
